1. Home
  2. BMRN vs PNFP Comparison

BMRN vs PNFP Comparison

Compare BMRN & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$55.50

Market Cap

10.9B

Sector

Health Care

ML Signal

HOLD

Logo Pinnacle Financial Partners Inc.

PNFP

Pinnacle Financial Partners Inc.

HOLD

Current Price

$87.47

Market Cap

12.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMRN
PNFP
Founded
1996
2000
Country
United States
United States
Employees
N/A
3595
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
12.5B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
BMRN
PNFP
Price
$55.50
$87.47
Analyst Decision
Buy
Buy
Analyst Count
18
16
Target Price
$88.22
$110.87
AVG Volume (30 Days)
1.8M
1.2M
Earning Date
04-30-2026
04-22-2026
Dividend Yield
N/A
2.29%
EPS Growth
N/A
N/A
EPS
1.80
N/A
Revenue
$1,313,646,000.00
N/A
Revenue This Year
$14.30
$163.66
Revenue Next Year
$11.65
$7.77
P/E Ratio
$30.84
$12.24
Revenue Growth
17.62
N/A
52 Week Low
$50.76
$81.08
52 Week High
$66.28
$120.39

Technical Indicators

Market Signals
Indicator
BMRN
PNFP
Relative Strength Index (RSI) 43.52 50.76
Support Level $54.67 $83.62
Resistance Level $56.21 $89.29
Average True Range (ATR) 1.54 2.10
MACD 0.07 0.88
Stochastic Oscillator 39.36 86.76

Price Performance

Historical Comparison
BMRN
PNFP

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

Share on Social Networks: